Package Leaflet: Information for the User
Tadalafil Combix 20 mg film-coated tablets EFG
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Tadalafil Combix is indicated for the treatment of erectile dysfunction in adult men. This occurs when a man cannot obtain or maintain a firm erection suitable for satisfactory sexual activity. Tadalafil Combix has been shown to significantly improve the ability to achieve a lasting erection of the penis suitable for sexual activity.
Tadalafil Combix contains the active ingredient tadalafil, which belongs to a group of medications called phosphodiesterase type 5 inhibitors. After sexual stimulation, Tadalafil Combix acts by helping to relax the blood vessels in the penis, allowing blood flow to the penis. The result is an improvement in erectile function. Tadalafil Combix will not help if you do not have erectile dysfunction.
It is essential to warn you that Tadalafil Combix is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Do not take Tadalafil Combix
Warnings and Precautions
Consult your doctor before starting to take Tadalafil Combix.
Be aware that sexual activity carries a possible risk in patients with heart problems, due to the additional effort it requires for the heart. If you have a heart problem, consult your doctor.
Before taking the tablets, inform your doctor if you have:
It is not known if tadalafil is effective in patients who have undergone:
If you experience a sudden decrease or loss of vision or your vision is distorted, blurred while taking Tadalafil Combix, stop taking Tadalafil Combix and contact your doctor immediately.
Tadalafil Combix is not intended for use in women.
Children and Adolescents
Tadalafil Combix should not be used in children or adolescents under 18 years of age.
Use of Tadalafil Combix with Other Medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to use any other medication.
Do not take tadalafil if you are already using nitrates.
Some medications may be affected by tadalafil or may affect the proper functioning of tadalafil. Inform your doctor or pharmacist if you are using:
Taking Tadalafil Combix with Drinks and Alcohol
Information about the effect of alcohol can be found in section 3. Grapefruit juice may affect the proper functioning of tadalafil and should be taken with caution. Consult your doctor for more information.
Fertility
In dogs treated with tadalafil, a decrease in sperm production by the testicles was observed. A reduction in sperm has been observed in some men. It is unlikely that these effects will produce a lack of fertility.
Driving and Using Machines
Some men who took tadalafil during clinical trials experienced dizziness. Carefully check how you react when taking the tablets before driving or using machines.
Tadalafil Combix contains lactose.If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions for this medication exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
The Tadalafil Combix tablets are for oral administration only in men. Swallow the tablet whole with a little water. The tablets can be taken with or without food.
The recommended initial doseis one 10 mg tablet before sexual activity. However, you have been given a dose of one 20 mg tablet because your doctor has decided that the recommended dose of 10 mg is too weak.
When taking Tadalafil Combix, you can initiate sexual activity at least 30 minutes after taking it.
Tadalafil Combix may still be effective up to 36 hours after taking the tablet.
Do not take Tadalafil Combix more than once a day. Tadalafil Combix 10 and 20 mg will be used before expected sexual activity and are not recommended for continuous daily use.
It is essential to warn you that Tadalafil Combix is not effective if there is no sexual stimulation. Therefore, you and your partner should stimulate each other in the same way as you would if you were not taking a medication for erectile dysfunction.
Consuming alcohol may affect your ability to have an erection and may temporarily lower your blood pressure. If you have taken or are planning to take Tadalafil Combix, avoid excessive alcohol consumption (blood alcohol level of 0.08% or higher), as it may increase the risk of dizziness when standing up.
If you take more Tadalafil Combix than you should
Consult your doctor. You may experience side effects described in section 4.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Tadalafil Combix
Take your dose as soon as you remember. Do not take a double dose to make up for forgotten doses. Do not take tadalafil more than once a day.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them. These effects are generally mild to moderate.
If you experience any of the following side effects, stop using the medication and seek medical help immediately:
Other side effects that have been reported:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1000 people)
Myocardial infarction and stroke have also been reported rarely in men taking tadalafil. Most of these men had pre-existing heart problems before taking this medication.
In men over 75 years of age treated with tadalafil, the most frequently reported adverse effect was dizziness. In men over 65 years of age treated with tadalafil, the most frequently reported adverse effect was diarrhea.
Rare cases of decreased or lost vision, partial, transient, or permanent in one or both eyes have been reported.
Some additional rare side effectshave been reported in men taking tadalafil that were not reported during clinical trials. These include:
Reporting Side Effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of in wastewater or household waste. Deposit the packaging and medications you no longer need in the SIGRE Point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Tadalafil Combix
Tablet core: lactose monohydrate, microcrystalline cellulose (E460i), hydroxypropylcellulose (E463), sodium croscarmellose, and magnesium stearate (E470b).
Tablet coating: Opadry II Yellow 32K520080 (hypromellose (E464), lactose monohydrate, titanium dioxide (E171), yellow iron oxide (E172), triacetin, and talc (E553b)).
Appearance of the Product and Package Contents
Yellow film-coated tablets, oval, biconvex, with beveled edges, engraved with "899" on one face and smooth on the other.
PVC/PVDC-Aluminum blisters.
Packaging of 2, 4, 8, and 12 tablets. Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Combix Laboratories, S.L.U.
C/Badajoz, 2. Building 2
28223 Pozuelo de Alarcón (Madrid)
Spain
Manufacturer
Zydus France
ZAC Les Hautes Patures
Parc d'activités des Peupliers
25 Rue des Peupliers
92000 Nanterre
France
or
Idifarma Pharmaceutical Development, S.L.
Mocholí Industrial Park
Noáin Street, 1
31110 Noáin (Navarra)
Spain
or
Netpharmalab Consulting Services
Fuencarral Road, 22
28108 Alcobendas (Madrid)
Spain
Date of the Last Revision of this Package Leaflet: November 2023
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es.